SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-027748
Filing Date
2018-10-30
Accepted
2018-10-30 21:33:33
Documents
1
Period of Report
2018-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9376
  Complete submission text file 0000899243-18-027748.txt   11401
Mailing Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND 44 (0) 207 932 2120
Advent Life Sciences LLP (Reporting) CIK: 0001601364 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38721 | Film No.: 181148519

Mailing Address 26 TECHNOLOGY DRIVE IRVINE CA 92618
Business Address 26 TECHNOLOGY DRIVE IRVINE CA 92618 949-396-6322
Axonics Modulation Technologies, Inc. (Issuer) CIK: 0001603756 (see all company filings)

IRS No.: 454744083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 158-160 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158-160 NORTH GOWER STREET LONDON X0 NW1 2ND 44 207 932 2100
Advent Life Sciences Fund II LP (Reporting) CIK: 0001614918 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38721 | Film No.: 181148520